“…The clinical phenotype of 22q11DS includes greater susceptibility to stress and anxiety, and poorer coping skills (Swillen et al, 1999;Beaton and Simon, 2011). Moreover, since children with 22q11DS often have to face medical (e.g., frequent hospitalizations and surgery (Mahle et al, 2003;Carotti et al, 2008)), cognitive (e.g., delayed cognitive development) (Gur et al, 2014;Swillen and McDonald-McGinn, 2015), and social challenges (e.g., bullying) (Swillen et al, 1999)) early in life, it is very likely that they may experience chronic stress, especially in infancy (Beaton and Simon, 2011;Vo et al, 2018). However, no study to date has investigated whether individuals with 22q11DS and healthy controls (HCs) differ in their experience of-and exposure to childhood adversity and chronic stress.…”